A avaliação no perfil das impurezas de fármacos está sendo alvo de atenção das agências regulatórias nacionais e internacionais visto que podem gerar implicações na saúde da população. Frente a isso, as indústrias farmacêuticas devem adequarse às novas regulamentações para garantir a qualidade, segurança e eficácia dos medicamentos. O fostato de sitagliptina (STG) e vildagliptina (VLG), liberados para uso clínico no Brasil em 2006 e 2007, respectivamente, são utilizados para o tratamento do diabetes mellitus tipo 2. Na literatura pesquisada não foram encontrados relatos referentes à determinação quantitativa de impurezas de síntese da vildagliptina e sitagliptina. Desta forma, este trabalho teve por objetivo desenvolver e validar métodos analíticos para a determinação de impurezas dos fármacos sitagliptina e vildagliptina, além de avaliar a toxicidade dos mesmos. Foi desenvolvido e validado método analítico por cromatografia líquida de alta eficiência para determinação do fosfato de sitagliptina na presença de duas impurezas de síntese de acordo com os parâmetros de especificidade, linearidade, precisão, exatidão, robustez, limites de detecção e quantificação. Para tanto, foi utilizada coluna cromatográfica XBridgeTM Pheny (250 mm x 4,6 mm, 5 μm), vazão 1,0 mL/min e detecção em 207 nm. A fase móvel foi composta por acetonitrila: solução aquosa em 0,05% de ácido fórmico (40:60, v/v). A determinação quantitativa da vildagliptina e duas impurezas de síntese foi desenvolvida e validada utilizando a técnica por cromatografia líquida de ultra-eficiência. A coluna cromatográfica utilizada corresponde ACQUITI UPLC® BEH C8 (50 x 2,1 mm; 1,7 μm), vazão 0,3 mL/min, volume de injeção de 1 μL e temperatura de 35°C. A fase móvel foi composta por metanol em ácido fórmico 0,1%: solução aquosa em ácido fórmico 0,1%. A partir dos resultados obtidos, verificou-se que estes estão de acordo com os requisitos preconizados pelos códigos oficiais. Esta pesquisa também apresenta resultados referentes aos estudos de citotoxicidade e genotoxicidade tanto dos fármacos quanto das respectivas impurezas realizados a partir dos ensaios de MTT, vermelho neutro, óxido nítrico, espécies reativas de oxigênio e nitrogênio, potencial de membrana mitocondrial e teste cometa. / Impurities profiling have attention of national and international regulatory agencies as they may generate implications for the health of the population. Against this, pharmaceutical industry must be suitable for new regulations to ensure quality, safety and efficacy of medicines. The phosphate sitagliptin and vildagliptin, released for clinical use in Brazil in 2006 and 2007, respectively, and used for the treatment of diabetes mellitus type 2. In the literature, we not found any reports regarding the quantitative determination of impurities synthesis of vildagliptin and sitagliptin. Thus, this study aimed to develop and validate analytical methods for the determination of impurities of sitagliptin and vildagliptin in addition to performing toxicological tests. It was developed and validated an analytical method by high-performance liquid chromatography for determination of sitagliptin in presence of two impurities synthesis according to the specific parameters, linearity, precision, accuracy, robustness, limits of detection and quantification. The XBridgeTM Phenyl column (250 mm x 4.6 mm d.i., 5 μm), flow rate 1.0 mL/min and detection at 207 nm. The mobile phase was composed of acetonitrile: aqueous solution in 0.05% formic acid (40:60, v/v). The results obtained are in accordance with the requirements recommended by official guides. Quantitative determination of vildagliptin and its synthetic impurities was developed using liquid chromatography ultra efficiency. The chromatographic column ACQUITY UPLC® BEH C8 (50 x 2.1 mm, 1.7 μm) was used, flow rate 0.3 mL/min, injection volume 1 μL and temperature 35 °C. The mobile phase is composed of methanol in formic acid 0.1%: aqueous solution in formic acid 0.1%. This research presents results for the cytotoxicity and genotoxicity studies of both drugs and the impurities.

Thesis (M.S.)--University of North Carolina at Wilmington, 2005. / Includes bibliographical references (leaves: 57-60)

A avaliação no perfil das impurezas de fármacos está sendo alvo de atenção das agências regulatórias nacionais e internacionais visto que podem gerar implicações na saúde da população. Frente a isso, as indústrias farmacêuticas devem adequarse às novas regulamentações para garantir a qualidade, segurança e eficácia dos medicamentos. O fostato de sitagliptina (STG) e vildagliptina (VLG), liberados para uso clínico no Brasil em 2006 e 2007, respectivamente, são utilizados para o tratamento do diabetes mellitus tipo 2. Na literatura pesquisada não foram encontrados relatos referentes à determinação quantitativa de impurezas de síntese da vildagliptina e sitagliptina. Desta forma, este trabalho teve por objetivo desenvolver e validar métodos analíticos para a determinação de impurezas dos fármacos sitagliptina e vildagliptina, além de avaliar a toxicidade dos mesmos. Foi desenvolvido e validado método analítico por cromatografia líquida de alta eficiência para determinação do fosfato de sitagliptina na presença de duas impurezas de síntese de acordo com os parâmetros de especificidade, linearidade, precisão, exatidão, robustez, limites de detecção e quantificação. Para tanto, foi utilizada coluna cromatográfica XBridgeTM Pheny (250 mm x 4,6 mm, 5 μm), vazão 1,0 mL/min e detecção em 207 nm. A fase móvel foi composta por acetonitrila: solução aquosa em 0,05% de ácido fórmico (40:60, v/v). A determinação quantitativa da vildagliptina e duas impurezas de síntese foi desenvolvida e validada utilizando a técnica por cromatografia líquida de ultra-eficiência. A coluna cromatográfica utilizada corresponde ACQUITI UPLC® BEH C8 (50 x 2,1 mm; 1,7 μm), vazão 0,3 mL/min, volume de injeção de 1 μL e temperatura de 35°C. A fase móvel foi composta por metanol em ácido fórmico 0,1%: solução aquosa em ácido fórmico 0,1%. A partir dos resultados obtidos, verificou-se que estes estão de acordo com os requisitos preconizados pelos códigos oficiais. Esta pesquisa também apresenta resultados referentes aos estudos de citotoxicidade e genotoxicidade tanto dos fármacos quanto das respectivas impurezas realizados a partir dos ensaios de MTT, vermelho neutro, óxido nítrico, espécies reativas de oxigênio e nitrogênio, potencial de membrana mitocondrial e teste cometa. / Impurities profiling have attention of national and international regulatory agencies as they may generate implications for the health of the population. Against this, pharmaceutical industry must be suitable for new regulations to ensure quality, safety and efficacy of medicines. The phosphate sitagliptin and vildagliptin, released for clinical use in Brazil in 2006 and 2007, respectively, and used for the treatment of diabetes mellitus type 2. In the literature, we not found any reports regarding the quantitative determination of impurities synthesis of vildagliptin and sitagliptin. Thus, this study aimed to develop and validate analytical methods for the determination of impurities of sitagliptin and vildagliptin in addition to performing toxicological tests. It was developed and validated an analytical method by high-performance liquid chromatography for determination of sitagliptin in presence of two impurities synthesis according to the specific parameters, linearity, precision, accuracy, robustness, limits of detection and quantification. The XBridgeTM Phenyl column (250 mm x 4.6 mm d.i., 5 μm), flow rate 1.0 mL/min and detection at 207 nm. The mobile phase was composed of acetonitrile: aqueous solution in 0.05% formic acid (40:60, v/v). The results obtained are in accordance with the requirements recommended by official guides. Quantitative determination of vildagliptin and its synthetic impurities was developed using liquid chromatography ultra efficiency. The chromatographic column ACQUITY UPLC® BEH C8 (50 x 2.1 mm, 1.7 μm) was used, flow rate 0.3 mL/min, injection volume 1 μL and temperature 35 °C. The mobile phase is composed of methanol in formic acid 0.1%: aqueous solution in formic acid 0.1%. This research presents results for the cytotoxicity and genotoxicity studies of both drugs and the impurities.

A avaliação no perfil das impurezas de fármacos está sendo alvo de atenção das agências regulatórias nacionais e internacionais visto que podem gerar implicações na saúde da população. Frente a isso, as indústrias farmacêuticas devem adequarse às novas regulamentações para garantir a qualidade, segurança e eficácia dos medicamentos. O fostato de sitagliptina (STG) e vildagliptina (VLG), liberados para uso clínico no Brasil em 2006 e 2007, respectivamente, são utilizados para o tratamento do diabetes mellitus tipo 2. Na literatura pesquisada não foram encontrados relatos referentes à determinação quantitativa de impurezas de síntese da vildagliptina e sitagliptina. Desta forma, este trabalho teve por objetivo desenvolver e validar métodos analíticos para a determinação de impurezas dos fármacos sitagliptina e vildagliptina, além de avaliar a toxicidade dos mesmos. Foi desenvolvido e validado método analítico por cromatografia líquida de alta eficiência para determinação do fosfato de sitagliptina na presença de duas impurezas de síntese de acordo com os parâmetros de especificidade, linearidade, precisão, exatidão, robustez, limites de detecção e quantificação. Para tanto, foi utilizada coluna cromatográfica XBridgeTM Pheny (250 mm x 4,6 mm, 5 μm), vazão 1,0 mL/min e detecção em 207 nm. A fase móvel foi composta por acetonitrila: solução aquosa em 0,05% de ácido fórmico (40:60, v/v). A determinação quantitativa da vildagliptina e duas impurezas de síntese foi desenvolvida e validada utilizando a técnica por cromatografia líquida de ultra-eficiência. A coluna cromatográfica utilizada corresponde ACQUITI UPLC® BEH C8 (50 x 2,1 mm; 1,7 μm), vazão 0,3 mL/min, volume de injeção de 1 μL e temperatura de 35°C. A fase móvel foi composta por metanol em ácido fórmico 0,1%: solução aquosa em ácido fórmico 0,1%. A partir dos resultados obtidos, verificou-se que estes estão de acordo com os requisitos preconizados pelos códigos oficiais. Esta pesquisa também apresenta resultados referentes aos estudos de citotoxicidade e genotoxicidade tanto dos fármacos quanto das respectivas impurezas realizados a partir dos ensaios de MTT, vermelho neutro, óxido nítrico, espécies reativas de oxigênio e nitrogênio, potencial de membrana mitocondrial e teste cometa. / Impurities profiling have attention of national and international regulatory agencies as they may generate implications for the health of the population. Against this, pharmaceutical industry must be suitable for new regulations to ensure quality, safety and efficacy of medicines. The phosphate sitagliptin and vildagliptin, released for clinical use in Brazil in 2006 and 2007, respectively, and used for the treatment of diabetes mellitus type 2. In the literature, we not found any reports regarding the quantitative determination of impurities synthesis of vildagliptin and sitagliptin. Thus, this study aimed to develop and validate analytical methods for the determination of impurities of sitagliptin and vildagliptin in addition to performing toxicological tests. It was developed and validated an analytical method by high-performance liquid chromatography for determination of sitagliptin in presence of two impurities synthesis according to the specific parameters, linearity, precision, accuracy, robustness, limits of detection and quantification. The XBridgeTM Phenyl column (250 mm x 4.6 mm d.i., 5 μm), flow rate 1.0 mL/min and detection at 207 nm. The mobile phase was composed of acetonitrile: aqueous solution in 0.05% formic acid (40:60, v/v). The results obtained are in accordance with the requirements recommended by official guides. Quantitative determination of vildagliptin and its synthetic impurities was developed using liquid chromatography ultra efficiency. The chromatographic column ACQUITY UPLC® BEH C8 (50 x 2.1 mm, 1.7 μm) was used, flow rate 0.3 mL/min, injection volume 1 μL and temperature 35 °C. The mobile phase is composed of methanol in formic acid 0.1%: aqueous solution in formic acid 0.1%. This research presents results for the cytotoxicity and genotoxicity studies of both drugs and the impurities.

M. Tech (Department of Chemistry, Faculty of Applied and Computer Sciences) Vaal University of Technology. / A simple and rapid method for determination of estrone (E1) and β-estradiol (E2) was developed and validated using high performance liquid chromatography (HPLC). The solutions of standards and sample were prepared with distilled water. HPLC separation was performed in isocratic method 50/50 (water/methanol) using 4.6 mm x 250 mm id film thickness 5 µm) XDB-C18 capillary column, detector DAD, UV on 254 nm, temperature 20 ºC with flow rate of 2 mL/min, sample volume 20 µL and run time of 10 min. Calibration curves were linear between concentration range 1.0 - 15.0 ppm. The method was validated for limit of detection and quantification, linearity, precision, trueness and specificity. Also the method was applied to directly and easily to the analysis of the E1 and E2. Adsorption experiments were carried out in batch mode using multistirrer in a series of Erlenmeyer flasks of 50 ml capacity covered to prevent contamination having concentration ranges of E1 and E2 from 1 to 10 mg/L with adsorbent dose range 0.01 to 1 g at pH range 1 to 10 and temperature range 15°C to 35°C, placed on multistirrer. The results of the batch studies showed that simultaneous adsorption shows the maximum percent (91%) removal of E1 and (86 %) E2 at optimum temperature 25 °C of adsorbent dose 0.1 g, and pH 7. The mechanism, isotherms and kinetics of removal of two endocrine disrupting chemicals, estrone (E1) and β-estradiol (E2) by activated carbon adsorption were investigated in an agitated non-flow batch adsorption studies. Mathematical models were used to describe the adsorption phenomenon with the kinetic and thermodynamic parameters evaluated using the adsorption equilibrium data at varying temperatures. Higher adsorption rates were achieved at acidic to neutral pH ranges, with the sorption kinetic data showing a good fit to the pseudo second order rate equation and the Langmuir adsorption isotherm model for both E1 and E2. The Gibbs free energy were –16.68 kJ/mol and –17.34 kJ/mol for E1 and E2 respectively. The values of enthalpy for both E1 (84.50 kJ/mol) and E2 (90 kJ/mol) indicated a chemical nature of the sorption process. Both the isotherm and thermodynamic data obtained all supported the mechanism of adsorption of E1 and E2 to be mainly chemisorption’s supported by some physical attractions.

M. Tech (Department of Chemistry, Faculty of Applied and Computer Sciences) Vaal University of Technology. / In this study, analytical method for determining the chlorinated phenols in water was developed using High Performance Liquid Chromatography. The following four compounds which are 2, 4, 6- Trichlorophenol (2, 4, 6 TCP), 3-chlorophenol (3CP), 2, 4- Dichlorophenol (2, 4 DCP) and 4-chloro-3-methylphenol (4C3MP) were identified and quantified with a High Performance Liquid Chromatography (HPLC). The validation parameters tested were,: linearity, trueness, precision, detection limit of quantitation, sensitivity, specificity, selectivity. The linear calibration ranges of five standard solution from 1-10 ppm. The linearity ranges between 0.9298-0.9813. The activated carbon based on the waste macadamia nutshell activated carbon (MAC) was investigated for its potential uses as an adsorbent for chlorinated phenols removal and compared with grafted macadamia nutshell activated carbon (GMAC). The adsorbent was characterized with Fourier transform infrared spectrophotometer (FTIR), scanning electron microscope (SEM) and thermo gravimetric analysis (TGA). The parameters such as pH, temperature, contact time, concentration and adsorbent were investigated by adsorption technique. The strata C18E has been used before for the same reason and therefore the research was based on mimic the functional group of solid phase extraction (SPE) into macadamia activated carbon (MAC). The functional groups in SPE C18E are benzene and octadecyl. MAC was grafted with strata C18E functional groups to compare its potential with the SPE. The pseudo-first-order and pseudo-second-order kinetic models were applied to verify the experimental data. The pseudo-second order exhibited the best fit for the kinetic studies for MAC adsorption. Chemical removal of chlorinated phenols from wastewater is necessary to reduce harmful products on the environment and human health. Chlorinated phenols have been previously listed as some of the highest priority contaminants and as well as mainly important capability carcinogenic toxins released from chemical plants. Their availability in water supplies was perceived by their bad taste and smell. The acceptable chlorinated phenols concentration in portable water is 1 (mg/l) base on the approval of world health organization. The permanent checking of chlorinated phenols in environmental samples has a greater significance and stresses highly effectiveness, common selectively and great sensitively methods. The maximum uptake of Phenol using weighed mass of MAC was found to be 78 % and for GMAC was 84% for both 2,4,6TCP. t=250 min, pH=5, Co=1mg/l, T = 25 oC and m = 0.3 g/l were the optimum condition for Phenol-MAC system and GMAC system. Over all analysis of equilibrium model analysis indicates the fitness of Langmuir isotherm model to Phenol MAC adsorption system, suggesting a monolayer adsorption of phenol on the surface of MAC. Phenol adsorption capacity of MAC was found to be decreasing with increase in temperature suggesting that the adsorption process was exothermic in nature, which was further supported by the negative values of change in enthalpy. Characterization of MAC and GMAC confirmed the mesoporous texture, highly carbonaceous nature and a higher effective surface area of 912 m2/g. The highest phenol uptake capacity of GMAC was found to be 8.0049 mg/g. The optimal conditions for various process parameters are t = 250 min, pH=5, Co=1mg/l, T = 25 oC and m = 0.3 g/l were the optimum condition for Phenol-GMAC system. Like Phenol-MAC system, the kinetics studies confirmed that Phenol-GMAC adsorption system can be described by pseudo- second-order kinetics model. Equilibrium model analysis indicates the fitness of Langmuir isotherm model to Phenol-MAC adsorption system, suggesting a monolayer adsorption of phenol on the surface of GMAC. Phenol adsorption capacity of GMAC was found to be decreasing with increase in temperature suggesting that the adsorption process was exothermic in nature, which was further supported by the negative values of change in enthalpy. The negative values of Gibb’s free energy suggested that adsorption of phenol onto GMAC was a spontaneous process.

Ultrahigh pressure liquid chromatography (UHPLC) makes it possible to use very small particles (< 2 µm) as packing materials to provide high column efficiencies. Results from a careful comparison of small porous and nonporous particles show that when the particle size is small enough (< 2 µm), both porous and nonporous particles give excellent performance, and the differences in column efficiencies between porous and nonporous particles become insignificant. Columns packed with bare diamond particles could separate small molecules, especially polar molecules, however, severe tailing occurred for less polar compounds. The polybutadiene coated diamond particles gave greater retention and better separation of small molecules compared to bare particles, although no improvement in column efficiency was observed. Changes in surface bonding of thermally hydrogenated diamond particles was achieved by chemical modification using various organic peroxides with or without reagents containing long carbon chain functional groups. It appears that the alkyl groups were attached onto the diamond surface with limited coverage. LC experiments did not demonstrate good separation; however, changes in LC behavior were observed. A repetitive solvent programming approach was successfully applied to the analysis of a continuous sample stream in microbore LC. Each analysis cycle consisted of three steps: pseudo-injection, elution and rinse. In the pseudo-injection step, elution with a non- or poor-eluting solvent produced a concentrated sample plug due to on-column focusing. Factors influencing peak symmetry, resolution and analysis cycle length were investigated. Quantitative analysis of a continuous sample stream is possible under certain operating conditions. Electric field gradient focusing (EFGF) devices with distributed resistor substrates could focus proteins in the separation channel, however, the focused bands were not stable, and the repeatability was poor due to the formation of bubbles and pH gradient in the separation channel. Both fiber-based and porous glass capillary-based planar EFGF devices with changing cross-sectional area (CCSA) channels were constructed and evaluated with the aid of a home-made scanning laser-induced fluorescence detection system. The fiber-based CCSA EFGF devices gave poorer performance compared with glass capillary based devices. Porous glass capillary-based EFGF devices could focus single proteins and separate mixtures of two to three proteins.

No description available.

High Pressure Liquid Chromatography (HPLC) is a well-known and widely used analytical technique which is prevalent throughout the pharmaceutical industry as a research tool. Despite its prominence HPLC possesses some disadvantages, most notably slow analysis time and large consumption of organic solvents. Ultra Pressure Liquid Chromatography (UPLC) is a relatively new technique which offers the same separation capabilities of HPLC with the added benefits of reduced run time and lower solvent consumption. One of the key developments which facilitate the new UPLC technology is sub 2-µm particles used as column packing material. These particles allow for higher operating pressures and increased flow rates while still providing strong separation. Although UPLC technology has been available since early 2000, few laboratories have embraced the new technology as an alternative to HPLC. Besides the resistance to investing in new capital, another major roadblock is converting existing HPLC methodology to UPLC without disruption. This research provides a framework for converting existing HPLC methods to UPLC. An existing HPLC method for analysis of Galantamine hydrobromide was converted to UPLC and validated according to ICH guidelines. A series of statistical evaluations on the validation data were performed to prove the equivalency between the original HPLC and the new UPLC method. This research presents this novel statistical strategy which can be applied to any two methodologies to determine parity. / Chemistry

HPLC has been used and can quickly determine several ions simultaneously. The method of determination described for transition metals [Cr(III), Fe(III), Ni(II), Co(II), Cu(II), Zn(II), Cd(II), Mn(II)] and [Ca(II), Pb(II)] using HPLC with UV-VIS detection is better than the PAR complexation method commonly used. The effects of both eluent pH and detector wavelength were investigated. Results from using different pHs and wavelengths, optional analytical conditions for the separation of [Ni(II), Co(II), Cu(II)], [Cr(III), Fe(III), Ca(II), Ni(II), Cu(II)], and [Ca(II), Zn(II), Pb(II)] in one injection, respectively, are described. The influence of adding different concentrations of Na_2EDTA solvent to the sample is shown. Detection limits, linear range, and the comparisons between this study and a post-column PAR method are given.